Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- HLN.LSE
- Price
- 365.50
- Stock movement up
- +7.90 (2.21%)
- Company name
- Haleon PLC
- Exchange
- (LSE ,
- Currency
- GBX )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 3305.20B
- Ent value
- 3321.36B
- Price/Sales
- 293.59
- Price/Book
- 197.83
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 3037.87
- Forward P/E
- 1909.61
- PEG
- -
- EPS growth
- -
- 1 year return
- 12.91%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-11
DIVIDENDS
HLN.LSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 3037.87 |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 293.59 |
| Price to Book | 197.83 |
| EV to Sales | 295.02 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 9.04B |
| EPS (TTM) | 0.12 |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 11.26B |
| Gross profit (TTM) | 6.83B |
| Operating income (TTM) | 2.01B |
| Net income (TTM) | 1.09B |
| EPS (TTM) | 0.12 |
| EPS (1y forward) | 0.19 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 60.68% |
| Operating margin (TTM) | 17.82% |
| Profit margin (TTM) | 9.66% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 531.00M |
| Net receivables | 2.14B |
| Total current assets | 4.71B |
| Goodwill | 0.00 |
| Intangible assets | 26.37B |
| Property, plant and equipment | 1.86B |
| Total assets | 33.40B |
| Accounts payable | 3.60B |
| Short/Current long term debt | 8.86B |
| Total current liabilities | 5.62B |
| Total liabilities | 16.69B |
| Shareholder's equity | 16.71B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 0.00 |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 0.00 |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 6.51% |
| Return on Assets | 3.26% |
| Return on Invested Capital | 4.27% |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 364.20 |
| Daily high | 369.50 |
| Daily low | 361.86 |
| Daily Volume | 30.6M |
| All-time high | 414.90 |
| 1y analyst estimate | 396.18 |
| Beta | 0.24 |
| EPS (TTM) | 0.12 |
| Dividend per share | - |
| Ex-div date | 24 Apr 2025 |
| Next earnings date | 8 May 2025 |
Downside potential
Loading...
Downside potential data
| HLN.LSE | S&P500 | |
| Current price drop from All-time high | -11.91% | -14.41% |
| Highest price drop | -22.23% | -56.47% |
| Date of highest drop | 5 Sep 2022 | 9 Mar 2009 |
| Avg drop from high | -6.42% | -11.07% |
| Avg time to new high | 19 days | 12 days |
| Max time to new high | 327 days | 1805 days |
COMPANY DETAILS
Marketcap
3305.20B
Marketcap category
Large-cap
Description
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Employees
25408
Website
Investor relations
-
SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found